Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05320835 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Setting Focus Overdose Prevention Intervention

Study acronym: Oasis
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: May 1, 2026 to Dec 1, 2026v6
  2. Primary completion date: Dec 1, 2025 to May 1, 2026
    • Study completion date: Jan 31, 2026 to May 30, 2027
    v5
  3. Re-verified, no change to tracked fieldsv4
  4. Collaborators expanded, about 6 words
    • Study title expanded, about 1 word
    v3
  5. Enrollment target: 120 to 285
    • Start date: Mar 28, 2022 to Apr 30, 2022
    • Primary completion date: Feb 20, 2026 to Dec 1, 2025
    • Study completion date: Feb 20, 2027 to Jan 31, 2026
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).
Trial Details
NCT Number NCT05320835
Lead Sponsor Johns Hopkins Bloomberg School of Public Health
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions
(from sponsor)		 HIV Infections, HCV, Drug Overdose
Related terms Drug Overdose, HIV Infections
Enrollment 285 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov